HeartBeam (NASDAQ: BEAT) was among the medical device companies highlighted in a Jan. 8 report by Modern Healthcare by ...

HeartBeam (NASDAQ: BEAT), a medical-technology company developing advanced electrocardiogram solutions, was featured in ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award ...

Time series electrocardiography combined with AI predicted cardiac arrest with remarkable accuracy. Discover how this ...

Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. (HSCS) d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company ...

NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, today announced results from a new study demonstrating that its AI-enabled ECG technology, AK-AVS™, can detect ...

HeartSciences Inc., an AI-powered medical technology company focused on transforming ECGs for earlier heart disease detection, provided a financial update for the third quarter of fiscal 2025, ...

FDA-cleared technology makes clinical-grade ECG insights for arrhythmia assessment available outside of a medical facility HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on ...

Sudden cardiac events (SCEs) are the leading cause of line-of-duty deaths (LODDs) among firefighters in the United States, so it is obvious why there is such an appeal for electrocardiogram (ECG) ...

HeartSciences is on track for a significant innovation in the healthcare space with the development of its MyoVista® wavECG™ device, which is approaching FDA submission, indicating progress toward ...

Conventional ECG patches often require cold gels and adhesives, which can cause skin irritation and leave marks. These materials can also lose effectiveness during vigorous movement, compromising ...